| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5902672 | Journal of Diabetes and its Complications | 2014 | 7 Pages |
Abstract
Saxagliptin improves glycemic control and is generally well tolerated in patients with T2DM, irrespective of concomitant statin therapy.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Brian Bryzinski, Elsie Allen, William Cook, Boaz Hirshberg,